导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.94% | 842/1050 |
| 近一周 | -4.00% | 975/1104 |
| 近一月 | -9.70% | 1025/1102 |
| 近一季 | -8.44% | 599/1092 |
| 近半年 | -11.11% | 797/1070 |
| 近一年 | -14.45% | 801/1018 |
| 近两年 | 59.78% | 432/926 |
| 近三年 | 13.27% | 567/834 |
| 成立以来 | 31.36% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.65% 934/1070 |
7.88% 575/1101 |
- - |
- - |
| 2025 | 16.40% 730/1065 |
9.04% 182/1014 |
-4.30% 938/1038 |
19.74% 617/1050 |
-6.84% 790/1065 |
| 2024 | 13.67% 205/1011 |
-6.14% 621/960 |
-12.42% 918/983 |
21.19% 49/991 |
14.10% 34/1011 |
| 2023 | 0.23% 93/952 |
28.46% 17/880 |
-0.52% 216/895 |
-16.80% 813/915 |
-5.73% 581/952 |
| 2022 | -24.87% 494/867 |
-19.88% 513/773 |
-0.01% 698/806 |
-11.56% 353/845 |
6.05% 164/867 |
| 2021 | 0.05% 347/740 |
-10.17% 497/580 |
11.66% 315/659 |
-5.03% 355/704 |
5.04% 221/740 |
| 2020 | 31.26% 343/554 |
1.97% 115/419 |
24.13% 208/466 |
0.18% 417/517 |
3.52% 459/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 华商计算机行业量化股票发起式A VS. 东吴新产业精选股票A(580008) |